Samrat Pharmachem Ltd
BSE:530125
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
215
410.15
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| IN |
|
Samrat Pharmachem Ltd
BSE:530125
|
668.9m INR |
Loading...
|
|
| US |
|
Sherwin-Williams Co
NYSE:SHW
|
88.7B USD |
Loading...
|
|
| US |
|
Ecolab Inc
NYSE:ECL
|
78.5B USD |
Loading...
|
|
| JP |
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
10.7T JPY |
Loading...
|
|
| CN |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
258B CNY |
Loading...
|
|
| CH |
|
Givaudan SA
SIX:GIVN
|
28.9B CHF |
Loading...
|
|
| IN |
|
Asian Paints Ltd
NSE:ASIANPAINT
|
2.6T INR |
Loading...
|
|
| DK |
|
Novozymes A/S
CSE:NZYM B
|
165.6B DKK |
Loading...
|
|
| US |
|
PPG Industries Inc
NYSE:PPG
|
24.7B USD |
Loading...
|
|
| CH |
|
Sika AG
F:SIKA
|
19.9B EUR |
Loading...
|
|
| CH |
D
|
DSM-Firmenich AG
AEX:DSFIR
|
17.2B EUR |
Loading...
|
Market Distribution
| Min | -153 833.3% |
| 30th Percentile | 2.7% |
| Median | 7.3% |
| 70th Percentile | 13.2% |
| Max | 9 977% |
Other Profitability Ratios
Samrat Pharmachem Ltd
Glance View
Samrat Pharmachem Ltd. engages in the manufacturing manufacturing and selling chemicals. The company is headquartered in Mumbai, Maharashtra. The firm is a supplier of iodine derivatives to the Indian and foreign market. The Company’s products include 3-5-Di Iodosalicylic Acid, Ammonium Iodide, Calcium Iodide, Clioquinol, Copper Iodide, Ethyl Iodide, Ethylenediamine Dihydroiodide, Hydroiodic Acid 57%, Iodic Acid, Iodine, Iodine Monochloride, Iodoquinol, Lithium Iodide, Methyl Iodide, N-Iodo Succcinimide, Periodic Acid, Potassium Iodate, Potassium Iodide, Potassium Metaper Iodate, Povidone Iodine, Selenium Dioxide, Sodium Iodate, Sodium Iodide, Sodium Metaper Iodate, Sodium Selenite, Tetra Butyl Ammonium Iodide, and Tri Methyl Sulphoxonium Iodide. The company serves various industries, such as agrochemical, animal feed, chemicals, food, pharmaceutical, printing, and textile. The firm exports its products to various countries, including United States, Europe, Africa, Asia, and Middle East.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Samrat Pharmachem Ltd is 1.2%, which is below its 3-year median of 3.2%.
Over the last 3 years, Samrat Pharmachem Ltd’s Operating Margin has decreased from 14.4% to 1.2%. During this period, it reached a low of -0.1% on Dec 31, 2023 and a high of 14.4% on Aug 30, 2022.